Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Peregrine Capital Management LLC

Peregrine Capital Management LLC boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 53.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 149,377 shares of the company’s stock after purchasing an additional 52,120 shares during the period. Peregrine Capital Management LLC’s holdings in Azenta were worth $7,469,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Farther Finance Advisors LLC lifted its position in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after buying an additional 256 shares in the last quarter. KBC Group NV lifted its holdings in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after purchasing an additional 698 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Azenta in the fourth quarter valued at about $200,000. Net Worth Advisory Group purchased a new stake in shares of Azenta during the third quarter worth about $205,000. Finally, Aigen Investment Management LP acquired a new position in shares of Azenta during the 3rd quarter worth about $214,000. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Price Performance

Shares of Azenta stock opened at $44.40 on Wednesday. The stock’s 50 day simple moving average is $50.49 and its 200-day simple moving average is $48.23. The stock has a market cap of $2.03 billion, a P/E ratio of -14.90 and a beta of 1.47. Azenta, Inc. has a 1-year low of $38.82 and a 1-year high of $67.77.

Azenta (NASDAQ:AZTA) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, research analysts expect that Azenta, Inc. will post 0.42 EPS for the current fiscal year.

Analyst Ratings Changes

AZTA has been the subject of several research reports. Evercore ISI boosted their price objective on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research note on Thursday, February 6th. Needham & Company LLC boosted their price target on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday, February 6th. Finally, Stephens restated an “overweight” rating and issued a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.